2 assets in Meniere Disease

Therapeutic assets addressing Meniere Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Topiramate Meniere Disease	University of California, Irvine	P4	BB (65)
Noramitriptyline Meniere Disease	University of California, Irvine	P4	BB (64)